- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Epilepsy
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Primidone – November 2019
Primidone: Tablet 250 mg; APO Primidone®
Last updated
9 July 2025